SCHEMBL6731056

SCHEMBL6731056

Fc1noc(-c2ccccc2)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.43
PTGS1 P23219 2/20 0.41
ALDH1A1 P00352 8/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
BRD4 O60885 2/20 0.39
BRD2 P25440 1/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 3/20 0.39
MAPK1 P28482 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TSHR P16473 2/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8376901 0.79 PTPN1 (0.44) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL17079305 0.75 PTPN1 (0.67) PTPN1PTGS1ALDH1A1MEN1KMT2A
SCHEMBL3751072 0.70 BRD4 (0.53) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL21105084 0.68 PTGS1 (0.55) PTPN1PTGS1ALDH1A1SMN1; SMN2MEN1
SCHEMBL21105338 0.68 BRD4 (0.68) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12002359 0.67 BRD4 (0.46) PTPN1PTGS1ALDH1A1SMN1; SMN2MEN1
SCHEMBL12000498 0.67 ALDH1A1 (0.46) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL6581665 0.67 PTPN1 (0.44) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL3751069 0.67 BRD4 (0.55) PTPN1PTGS1ALDH1A1SMN1; SMN2HPGD
SCHEMBL3925819 0.67 BRD4 (0.50) PTPN1PTGS1ALDH1A1SMN1; SMN2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTPN1 853/4885PTGS1 4/4885ALDH1A1 434/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTPN1 853/4885PTGS1 4/4885ALDH1A1 434/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTPN1 853/4885PTGS1 4/4885ALDH1A1 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.